Japan’s Switch Committee Resists Full Reform
Japan’s Rx-to-OTC Switching Evaluation Committee has accepted most of the reforms mandated by the country’s government as part of its attempt to reform the national medicines reclassification system. However, it still has more of a role than industry would perhaps like.
You may also be interested in...
Japan’s Supreme Court has delivered a final ruling on a seven year dispute over online sales of non-prescription medicines. The Court has rejected a complaint against the ban on distant selling of OTCs in the most-strictly-regulated category, that of recently switched drugs. Meanwhile, the Japanese government is extending the country’s Self-Medication Tax Deduction System for another five years.
The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches.
“We urgently need the adoption of an EU wide regulation on sound scientific THC limits in food,” insisted EIHA president and Hempro International CEO Daniel Kruse at the association's 18th annual conference, “Hemp for Europe: Emerging opportunities for the Green Recovery.”